Identification of 1-butyl-3-(1-(4-methyl)naphtoyl)indole detected for the first time in “herbal high” products on the Italian market
Authors:
- Ermanno ValotiEVErmanno Valoti
- Eleonora CasagniECEleonora Casagni
- Lucia Dell’aCquaLDLucia Dell’aCqua
- Marco PallaviciniMPMarco Pallavicini
- Gabriella RodaGRGabriella Roda
- Chiara RusconiCRChiara Rusconi
- Valentina StranieroVSValentina Straniero
- Veniero GambaroVGVeniero Gambaro
- 1 November 2012
- journal article
- Published by Elsevier in Forensic Science International
- Vol. 223 (1-3) , e42-e46
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of “herbal highs” compositionAnalytical and Bioanalytical Chemistry, 2011
- Beyond THC: The New Generation of Cannabinoid Designer DrugsFrontiers in Behavioral Neuroscience, 2011
- Spice: A never ending story?Forensic Science International, 2009
- ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?Journal of Mass Spectrometry, 2009
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesBioorganic & Medicinal Chemistry Letters, 2005
- Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonistsBioorganic & Medicinal Chemistry, 2005
- 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptorBioorganic & Medicinal Chemistry, 2003
- Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor bindingDrug and Alcohol Dependence, 2000
- Design, Synthesis and Pharmacology of Cannabimimetic IndolesBioorganic & Medicinal Chemistry Letters, 1994